Diluting 5-fluorouracil with normal saline reduces patient discomfort
Abstract
5-Fluorouracil (5-FU) is an antimetabolite and is used to improve the success rate of trabeculectomies by inhibition of subconjunctival fibrosis. It can be administered postoperatively as a subconjunctival injection or given intraoperatively via cellulose sponge soaked in 5-FU and placed between the sclera and conjunctival flap. The advantage of injecting 5-FU subconjunctivally postoperatively is that the dose and frequency can be titrated according to patients’ needs. Subconjunctival injection may be uncomfortable and this could be due to the alkaline nature of 5-FU (pH 9.20) and its osmolarity of 384 mmol/l. It would be beneficial if this discomfort can be minimised as the injection may need to be given several times.
References
Copyright (c) 2019 Keith Ong, Ru Ming Ong, Daisy Shu
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication, with the work twelve (12) months after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
